|Calculated MW||95348 Da|
|Immunogen||Recombinant human CD22.|
|Shelf Life||18 months from date of despatch.|
|Other Names||B-cell receptor CD22, B-lymphocyte cell adhesion molecule, BL-CAM, Sialic acid-binding Ig-like lectin 2, Siglec-2, T-cell surface antigen Leu-14, CD22, CD22, SIGLEC2|
|Target/Specificity||Mouse anti-Human CD22 antibody, clone FPC1 recognizes the human CD22 cell surface antigen, a ~130-140 kDa glycoprotein.CD22 is expressed within the cytoplasm at an early stage of B cell differentiation, but is expressed at the membrane only on mature B lymphocytes. CD22 expression is lost during terminal differentiation to plasma cell stages.|
|Preservative & Stabilisers||15mM Sodium Azide|
|Storage||Storage at 4℃ or at -20℃.|
|Precautions||Anti-Human CD22 Antibody, clone FPC1 is for research use only and not for use in diagnostic or therapeutic procedures.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
1. Gattenlöhner, S. et al. (2003) NCAM(CD56) and RUNX1(AML1) are up-regulated in human ischemic cardiomyopathy and a rat model of chronic cardiac ischemia.Am J Pathol. 163 (3): 1081-90.
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at firstname.lastname@example.org.